Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC). (Q46659777)
Jump to navigation
Jump to search
scientific article published on 3 April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC). |
scientific article published on 3 April 2008 |
Statements
Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC) (English)
L Decoster
D Schallier
H Everaert
K Nieboer
M Meysman
B Neyns